Menu Back toBioclinica Lunch and Learn: The Power of AI in Advancing the Clinical Trial Lifecycle
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Bioclinica Lunch and Learn: The Power of AI in Advancing the Clinical Trial Lifecycle
- United States
Artificial Intelligence (AI) technology is pushing the boundaries of what’s possible across all aspects of life sciences, particularly in the clinical trial lifecycle. Join us for an important discussion about how integrating AI capabilities within cloud-native solutions is giving Sponsors and Core Labs a competitive edge while meeting project timelines and complying with regulatory guidelines.
Utilizing AI throughout workflows for trial eligibility, data collection, adjudication, and image reviews enhances efficiency and reduces the risk of manual error. Learn how AI-enabled clinical trial products, processes, and services save time, reduce costs, and mitigate the risk of non-compliance in three critical areas of the clinical trial lifecycle
- PHI redaction of source documents
- Automatic segmentation, classification, and measurements in imaging
- PHI redaction in videos and movement studies
- Director, Medical Imaging Technologies, Research & Development
- Bioclinica, an ERT Company, United States
Janine M. Jones, BSN, MBA, RN
- Senior Product Manager
- BioClinica, United States